“From Weeks to Seconds”: Intel Stock (NASDAQ:INTC) Takes Aim at Medical Market

Can you picture chip stock Intel (INTC) as a healthcare company? Sure, healthcare runs on computers these days, but Intel may have a whole new tool that is delivering shocking value in the detection of eye lesions. It has dropped the time required to spot these “from weeks to seconds,” the reports note, and that in turn is offering value for patients everywhere. Intel shareholders are pleased too, with shares up nearly 3% in Tuesday afternoon’s trading.

Intel’s chips are backing an AI PC built by Acer Medical, which in turn calls on the VeriSee DR system and the VeriSee AMD system to produce the amazing results. VeriSee DR focuses on diabetic retinopathy, while the VeriSee AMD system focuses on age-related macular degeneration. These two tools are used in conjunction with what is called a fundus camera that can take “high-resolution pictures of the inner eye,” and send these scans to the AI PC in question. The PC can then scan the images looking for key telltale details that suggest a condition in progress.

Currently, the VeriSee AMD is about 95% accurate, but reports note that that is improving as the AI models in question are trained. That gives Intel a valuable new connection in the healthcare market, and the eldercare market as well, which is on the rise. With elder care already a trillion-dollar market, getting a piece of that might be a big advantage for Intel going forward.

A Powerful New Gaming Chip

Meanwhile, new reports say that Intel is already well underway in building a new chip that should get PC gamers’ attention in a big way. The new PC in question, according to reports, is a “12-core Bartlett Lake S” model that has no E-cores, and will be branded under the Core 2 lineup. All 12 of the cores involved will be P-cores, or Performance cores, which could make this a gaming powerhouse.

Early word says that the new chip in question will actually pack more power than the Core i9 14900K, which is an impressive idea in and of itself. About the only thing that is unclear is what kind of clock speed the new chip will boast; if that is sufficiently high, then this could be a boost for Intel as well. Moreover, the new chips will use the same LGA1700 motherboard socket that the current line of 12^th , 13^th, and 14th-generation chips use, making it an easy upgrade for those already running high-performance systems.

Is Intel a Buy, Hold or Sell?

Turning to Wall Street, analysts have a Hold consensus rating on INTC stock based on two Buys, 25 Holds and four Sells assigned in the past three months, as indicated by the graphic below. After a 34.27% loss in its share price over the past year, the average INTC price target of $21.29 per share implies 4.8% upside potential.

See more INTC analyst ratings

Disclosure